The CRO concept sector boosted in the short term, with Innolaser and Wanbang Pharmaceuticals rising by more than 10%, while nearshore protein, Oppo Mai, Chengdu Pioneer, Medici, and Hongbo Pharmaceuticals followed suit. In terms of related ETFs, the biomedical ETF Tianhong rose 1.33%, with a turnover of 477.19,500 yuan. The biomedical ETF Huitianfu rose 1.15%, with a turnover of 126.632 million yuan.

The CRO concept sector boosted in the short term, with Innolaser and Wanbang Pharmaceuticals rising by more than 10%, while nearshore protein, Oppo Mai, Chengdu Pioneer, Medici, and Hongbo Pharmaceuticals followed suit. In terms of related ETFs, the biomedical ETF Tianhong rose 1.33%, with a turnover of 477.19,500 yuan. The biomedical ETF Huitianfu rose 1.15%, with a turnover of 126.632 million yuan.